Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 289

1.

Microinvasive breast cancer and the role of sentinel node biopsy: an institutional experience and review of the literature.

Guth AA, Mercado C, Roses DF, Darvishian F, Singh B, Cangiarella JF.

Breast J. 2008 Jul-Aug;14(4):335-9. doi: 10.1111/j.1524-4741.2008.00594.x. Review.

PMID:
18537917
2.

Sentinel lymph node metastasis from mammary ductal carcinoma in situ with microinvasion.

Zavagno G, Belardinelli V, Marconato R, Carcoforo P, Franchini Z, Scalco G, Burelli P, Pietrarota P, Mencarelli R, Marconato G, Nitti D.

Breast. 2007 Apr;16(2):146-51. Epub 2006 Oct 12.

PMID:
17046258
3.

Sentinel lymph node metastasis in microinvasive breast cancer.

Intra M, Zurrida S, Maffini F, Sonzogni A, Trifirò G, Gennari R, Arnone P, Bassani G, Opazo A, Paganelli G, Viale G, Veronesi U.

Ann Surg Oncol. 2003 Dec;10(10):1160-5.

PMID:
14654471
4.

The value of sentinel lymph node biopsy in ductal carcinoma in situ (DCIS) and DCIS with microinvasion of the breast.

van la Parra RF, Ernst MF, Barneveld PC, Broekman JM, Rutten MJ, Bosscha K.

Eur J Surg Oncol. 2008 Jun;34(6):631-5. Epub 2007 Sep 11.

PMID:
17851019
5.

Ductal carcinoma in situ: value of sentinel lymph node biopsy.

Sakr R, Barranger E, Antoine M, Prugnolle H, Daraï E, Uzan S.

J Surg Oncol. 2006 Oct 1;94(5):426-30. Review.

PMID:
16967457
6.

Outcome of patients with ductal carcinoma in situ and sentinel node biopsy.

Meretoja TJ, Heikkilä PS, Salmenkivi K, Leidenius MH.

Ann Surg Oncol. 2012 Jul;19(7):2345-51. doi: 10.1245/s10434-012-2287-5. Epub 2012 Mar 7.

PMID:
22395995
7.

Sentinel lymph node biopsy for ductal carcinoma in situ: an evolving approach at the University of Florida.

Camp R, Feezor R, Kasraeian A, Cendan J, Schell S, Wilkinson E, Copeland E, Lind S.

Breast J. 2005 Nov-Dec;11(6):394-7.

PMID:
16297082
8.

Lymph node metastasis from ductal carcinoma in situ with microinvasion.

Zavotsky J, Hansen N, Brennan MB, Turner RR, Giuliano AE.

Cancer. 1999 Jun 1;85(11):2439-43.

PMID:
10357415
9.

An update of sentinel lymph node mapping in patients with ductal carcinoma in situ.

Wilkie C, White L, Dupont E, Cantor A, Cox CE.

Am J Surg. 2005 Oct;190(4):563-6.

PMID:
16164920
10.

Tumor size as predictor of microinvasion, invasion, and axillary metastasis in ductal carcinoma in situ.

Maffuz A, Barroso-Bravo S, Nájera I, Zarco G, Alvarado-Cabrero I, Rodríguez-Cuevas SA.

J Exp Clin Cancer Res. 2006 Jun;25(2):223-7.

PMID:
16918134
11.

Cost/accuracy ratio analysis in breast cancer patients undergoing ultrasound-guided fine-needle aspiration cytology, sentinel node biopsy, and frozen section of node.

Genta F, Zanon E, Camanni M, Deltetto F, Drogo M, Gallo R, Gilardi C.

World J Surg. 2007 Jun;31(6):1155-63.

PMID:
17464539
12.

Risk factors for lymph node metastases in breast ductal carcinoma in situ with minimal invasive component.

Wasserberg N, Morgenstern S, Schachter J, Fenig E, Lelcuk S, Gutman H.

Arch Surg. 2002 Nov;137(11):1249-52.

PMID:
12413311
13.

[Ductal carcinoma in situ of the breast with microinvasion. Role of sentinel lymph node biopsy].

Le Bouëdec G, de Lapasse C, Mishellany F, Chêne G, Michy T, Gimbergues P, Dauplat J.

Gynecol Obstet Fertil. 2007 Apr;35(4):317-22. Epub 2007 Mar 6. French.

PMID:
17344087
14.

Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion?

Klauber-DeMore N, Tan LK, Liberman L, Kaptain S, Fey J, Borgen P, Heerdt A, Montgomery L, Paglia M, Petrek JA, Cody HS, Van Zee KJ.

Ann Surg Oncol. 2000 Oct;7(9):636-42.

PMID:
11034239
15.

What is the value of axillary dissection or sentinel node biopsy in patients with ductal carcinoma in situ?

Mabry H, Giuliano AE, Silverstein MJ.

Am J Surg. 2006 Oct;192(4):455-7.

PMID:
16978948
16.

Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit.

Moore KH, Sweeney KJ, Wilson ME, Goldberg JI, Buchanan CL, Tan LK, Liberman L, Turner RR, Lagios MD, Cody Iii HS, Giuliano AE, Silverstein MJ, Van Zee KJ.

Ann Surg Oncol. 2007 Oct;14(10):2911-7. Epub 2007 Jun 28.

PMID:
17597346
17.

Sentinel node biopsy is not a standard procedure in ductal carcinoma in situ of the breast: the experience of the European institute of oncology on 854 patients in 10 years.

Intra M, Rotmensz N, Veronesi P, Colleoni M, Iodice S, Paganelli G, Viale G, Veronesi U.

Ann Surg. 2008 Feb;247(2):315-9. doi: 10.1097/SLA.0b013e31815b446b.

PMID:
18216539
18.

Frequency of sentinel lymph node metastases in patients with favorable breast cancer histologic subtypes.

Wong SL, Chao C, Edwards MJ, Carlson DJ, Laidley A, Noyes RD, McGlothin T, Ley PB, Tuttle T, Schadt M, Pennington R, Legenza M, Morgan J, McMasters KM; University of Louisville Breast Cancer Study Group.

Am J Surg. 2002 Dec;184(6):492-8; discussion 498.

PMID:
12488144
19.

Axillary node staging for microinvasive breast cancer: is it justified?

Lyons JM 3rd, Stempel M, Van Zee KJ, Cody HS 3rd.

Ann Surg Oncol. 2012 Oct;19(11):3416-21. doi: 10.1245/s10434-012-2376-5. Epub 2012 May 11.

PMID:
22576061
20.

The prevalence of axillary lymph-node metastases in patients with pure tubular carcinoma of the breast and sentinel node biopsy.

Leikola J, Heikkilä P, von Smitten K, Leidenius M.

Eur J Surg Oncol. 2006 Jun;32(5):488-91. Epub 2006 Mar 29.

PMID:
16569494
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk